nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A dose of optimism
|
Lee, John A |
|
2003 |
4 |
2 |
p. 130- 1 p. |
artikel |
2 |
Advances in the treatment of hairy-cell leukaemia
|
Mey, Ulrich |
|
2003 |
4 |
2 |
p. 86-94 9 p. |
artikel |
3 |
A legislative minefield
|
The Lancet Neurology, |
|
2003 |
4 |
2 |
p. 63- 1 p. |
artikel |
4 |
A model for decision making for the use of radiotherapy in lung cancer
|
Delaney, Geoff |
|
2003 |
4 |
2 |
p. 120-128 9 p. |
artikel |
5 |
An out-of-body experience
|
Wilkinson, Emma |
|
2003 |
4 |
2 |
p. 64- 1 p. |
artikel |
6 |
Beyond information—leukaemia sites offer hope and support
|
Larkin, Marilynn |
|
2003 |
4 |
2 |
p. 129- 1 p. |
artikel |
7 |
“Cancer germ” bacteria isolated
|
Sansom, Clare |
|
2003 |
4 |
2 |
p. 66- 1 p. |
artikel |
8 |
Cancer prevention and delay are as important as cure
|
Gescher, Andreas J |
|
2003 |
4 |
2 |
p. 72-73 2 p. |
artikel |
9 |
Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies
|
Juretic, Antonio |
|
2003 |
4 |
2 |
p. 104-109 6 p. |
artikel |
10 |
Defects in tubulin assembly machinery underlie disease
|
Chande, Minal |
|
2003 |
4 |
2 |
p. 67- 1 p. |
artikel |
11 |
‘Desensitising’ gene therapy blocks TGFβ
|
Ahmad, Khabir |
|
2003 |
4 |
2 |
p. 65- 1 p. |
artikel |
12 |
Engineered anthrax toxin has potent antitumour activity
|
Brown, Hannnah |
|
2003 |
4 |
2 |
p. 64- 1 p. |
artikel |
13 |
Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS
|
Dal Maso, Luigino |
|
2003 |
4 |
2 |
p. 110-119 10 p. |
artikel |
14 |
Erratum
|
|
|
2003 |
4 |
2 |
p. 74- 1 p. |
artikel |
15 |
ESMO committed to improving cancer education
|
Ludwig, Heinz |
|
2003 |
4 |
2 |
p. 71-72 2 p. |
artikel |
16 |
Gloomy prospects for European cancer research
|
Habeck, Martina |
|
2003 |
4 |
2 |
p. 66- 1 p. |
artikel |
17 |
Improving palliative care for cancer
|
Higginson, Irene J |
|
2003 |
4 |
2 |
p. 73-74 2 p. |
artikel |
18 |
Jamestown Canyon virus implicated in colon cancer
|
Boughton, Barbara |
|
2003 |
4 |
2 |
p. 65- 1 p. |
artikel |
19 |
Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias
|
Gambacorti-Passerini, Carlo B |
|
2003 |
4 |
2 |
p. 75-85 11 p. |
artikel |
20 |
Normal and neoplastic prostate cells have EPO receptors
|
Brower, Vicki |
|
2003 |
4 |
2 |
p. 69- 1 p. |
artikel |
21 |
Radiofrequency ablation for localised breast cancer
|
Kerr, Cathel |
|
2003 |
4 |
2 |
p. 68- 1 p. |
artikel |
22 |
Replication checkpoint protects chromosomal fragile sites
|
Ahmad, Khabir |
|
2003 |
4 |
2 |
p. 67- 1 p. |
artikel |
23 |
Rituximab for BCL-2-positive cancers
|
Boughton, Barbara |
|
2003 |
4 |
2 |
p. 69- 1 p. |
artikel |
24 |
Routine vaccinations safe for immunocompromised patients
|
Bonn, Dorothy |
|
2003 |
4 |
2 |
p. 68- 1 p. |
artikel |
25 |
Splenic marginal-zone lymphoma: a distinct clinical and pathological entity
|
Thieblemont, Catherine |
|
2003 |
4 |
2 |
p. 95-103 9 p. |
artikel |
26 |
Study links level of DNA damage to arsenic exposure
|
Orellana, Claudia |
|
2003 |
4 |
2 |
p. 70- 1 p. |
artikel |
27 |
Thalidomide: no benefit in myelofibrosis with myeloid metaplasia
|
Bonn, Dorothy |
|
2003 |
4 |
2 |
p. 70- 1 p. |
artikel |